NEW YORK, Dec. 18 (GenomeWeb News) - Tranzyme has acquired Québec-based Neokimia, the companies said today.
Financial details were not disclosed. However, Vipin Garg, president and CEO of Tranzyme, said both companies were valued at around $7.5 million at the time of the deal.
Registering provides access to this and other free content.
Already have an account?Login Now.
Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.
Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.
China is embracing preimplantation genetic diagnosis, Nature News reports.
In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.